What is Sepalika?
Sepalika operates as an online clinic dedicated to women's hormonal health, offering evidence-based holistic care. The company leverages nutrition, dietary supplements, acupressure, and lifestyle modifications to create customized treatment plans for conditions such as painful periods, PCOD, and cystic acne, while also supporting natural fertility. Sepalika's model caters to women seeking to manage hormonal imbalances and achieve overall well-being through natural remedies and lifestyle adjustments, all accessible from home.
How much funding has Sepalika raised?
Sepalika has raised a total of $750K across 1 funding round:
Angel/Seed
$750K
Angel/Seed (2017): $750K with participation from Accel Partners
Key Investors in Sepalika
Accel Partners
Accel Partners is a prominent venture capital firm known for its early-stage investments in technology and healthcare companies. Their backing of Sepalika suggests a belief in the company's innovative approach to women's health and its potential for significant market impact.
What's next for Sepalika?
The substantial enterprise-level funding indicates Sepalika is poised for significant expansion. This capital injection will likely fuel advancements in their platform, broaden their service offerings, and enhance their reach within the women's health market. Future strategic initiatives may include further integration of telehealth capabilities, development of new supplement lines, and expansion into adjacent health verticals, solidifying their position as a leader in personalized, holistic women's healthcare.
See full Sepalika company page
